Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Design and Pharmacology of N-[(3 R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1 R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1 H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist

Open access
Sebhat, Iyassu K., Martin, William J., Ye, Zhixiong, Barakat, Khaled, Mosley, Ralph T., Johnston, David B. R., Bakshi, Raman, Palucki, Brenda, Weinberg, David H., MacNeil, Tanya, Kalyani, Rubana N., Tang, Rui, Stearns, Ralph A., Miller, Randy R., Tamvakopoulos, Constantin, Strack, Alison M., McGowan, Erin, Cashen, Doreen E., Drisko, Jennifer E., Hom, Gary J., Howard, Andrew D., MacIntyre, D. Euan, van der Ploeg, Lex H. T., Patchett, Arthur A., Nargund, Ravi P. · 2002 · Journal of Medicinal Chemistry

Abstract

Synthetic and natural peptides that act as nonselective melanocortin receptor agonists have been found to be anorexigenic and to stimulate erectile activity. We report the design and development of 1, a potent, selective (1184-fold vs MC3R, 350-fold vs MC5R), small-molecule agonist of the MC4 receptor. Pharmacological testing confirms the food intake lowering effects of MC4R agonism and suggests another role for the receptor in the stimulation of erectile activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/jm025539h

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 193

Metadata

Authors
Sebhat, I. K., Martin, W. J., Ye, Z., Barakat, K., Mosley, R. T., Johnston, D. B. R., Bakshi, R., Palucki, B., Weinberg, D. H., MacNeil, T., Kalyani, R. N., Tang, R., Stearns, R. A., Miller, R. R., Tamvakopoulos, C., Strack, A. M., McGowan, E., Cashen, D. E., Drisko, J. E., Hom, G. J., Howard, A. D., MacIntyre, D. E., van der Ploeg, L. H. T., Patchett, A. A., & Nargund, R. P.
Venue
Journal of Medicinal Chemistry
Published
2002-09-14
Volume
45
Issue
21
Pages
4589-4593
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2032447576
Cited by
193
References
1
FWCI
6.59
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Design and Pharmacology of N-[(3 R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1 R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1 H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist. https://app.cochat.ai/papers/10.1021/jm025539h
The paper
Sebhat, I. K., Martin, W. J., Ye, Z., Barakat, K., Mosley, R. T., Johnston, D. B. R., Bakshi, R., Palucki, B., Weinberg, D. H., MacNeil, T., Kalyani, R. N., Tang, R., Stearns, R. A., Miller, R. R., Tamvakopoulos, C., Strack, A. M., McGowan, E., Cashen, D. E., Drisko, J. E., . . . Nargund, R. P. (2002). Design and Pharmacology of N-[(3 R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1 R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1 H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist. Journal of Medicinal Chemistry. https://doi.org/10.1021/jm025539h

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.